Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KARKANT AS
AS
Active
Org 923196706
Moer Allé 33, 1435 Ås
Engineering activities and related technical consultancy · NACE 7112
Est. 2019
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 0
EBITDA margin
—
+90% vs 2022
Equity ratio
82.9%
Financial strength
Net profit 2023
NOK -21K
+90% vs 2022
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 0
—
EBITDA
NOK -21K
+90%
Net profit
NOK -21K
+90%
Total assets
NOK 43K
-91%
Equity
NOK 35K
+961%
Employees
0
—
Company information
Legal name
KARKANT AS
Org number
923196706
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
14. august 2019
Share capital
NOK 120 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikle diagnostiske hurtigtester innen oppdrett av marinearter, herunder laks.
Contact
Address
Moer Allé 33, 1435 Ås
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Ås
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
1M
2022
0M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
Income statement
NOK thousands
Item
2019
2020
2021
2022
2023
Revenue
103
20
0
652
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
0
−24
−0
−204
−21
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
0
−24
−0
−204
−21
Net financials
0
0
0
0
0
Profit before tax
0
−24
−0
−204
−21
Tax
−0
−0
−0
−0
−0
Net profit
0
−24
−0
−204
−21
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
2023
Total assets
74
0
1
488
43
Equity
24
0
−0
−4
35
Long-term debt
0
0
0
0
0
Short-term debt
50
0
1
492
7
Total debt
50
0
1
492
7
Financial ratios
5-year trend
EBITDA margin
-2055200.0%
This company
15.8%
Market median
-13007695% vs market
2019
2023
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
2019
2023
Return on equity
-58.1%
This company
18.4%
Market median
-416% vs market
2019
2023
Net profit margin
-2055200.0%
This company
8.1%
Market median
-25372940% vs market
2019
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2023
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
JU
Jørn Ulheim
Chairman
2022
—
—
KS
Kristoffer Stenstad
Board of Directors
2022
—
—
AT
Andrew Thomas Campbell
Board of Directors
2022
—
—
PL
Per Lundell
Board of Directors
2022
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
50.0%
50.0%
2022
Patogen As
Company
50.0%
50.0%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Fürst Holding As
Dr Furst Medisinsk Laboratorium As
Patogen As
KARKANT AS
(this company)
Board network connections
Board members of KARKANT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jørn Ulheim
Chairman
0 companies
Kristoffer Stenstad
Board of Directors
0 companies
Andrew Thomas Campbell
Board of Directors
0 companies
Per Lundell
Board of Directors
0 companies